Five early-career researchers have been awarded four-year fellowships under the LUMC Junior Principal Investigator (PI) Programme 2025. Each receives €850,000 to launch an independent research line within LUMC, with a strong emphasis on translating scientific insight into clinical application.
This year’s awardees include researchers working on personalised interventions for cardiometabolic diseases, new immunotherapies targeting B cells, brain waste clearance mechanisms, host–pathogen interactions, and chronic inflammation in IBD. The diversity of topics reflects LUMC’s focus on high-impact research that cuts across traditional disciplinary boundaries.
The programme is designed to accelerate the careers of talented postdocs by offering them full research independence, a formal PI status, and access to core facilities. It also strengthens LUMC’s position as a national leader in developing future scientific leadership. Each fellow will lead a small team and is expected to compete for follow-up funding through major national and international schemes.
The 2026 call is now open, and applicants are encouraged to align their proposals with LUMC’s strategic research themes.
Meet the 2025 fellows and learn how to apply for the next round here.
Leiden, 26 November 2025 – INFECTA, a Dutch clinical research organization specializing in infectious diseases, has signed a cooperation agreement with AHAM Vastgoed for the...
With construction in full swing, the new University Sports Centre (USC) is set to open its doors on December 1, 2025. The first visitors will be welcomed in February 2026,...
The Dutch Research Council (NWO) is investing €197 million in 11 large-scale research infrastructure projects that benefit both science and society. Leiden University and Leiden...